1. Testosterone Physicians

Category Archives: Testosterone Physicians

Testosterone Replacement Therapy – Royal Medical Center

Posted on by

There are three main medications for testosterone treatment

Testosterone is used to increase and optimize hormone levels. The dosage varies and is determined by the prescribing physician. A patients medical history, lab results and physical are all factored in during diagnosis.HCG is used to prevent testicular shrinkage and maintain the natural production of the hormone in the testes.An Estrogen Blocker is used to control the levels of estrogen in mens bodies.

Our doctors have designed a safe and proven program for our patients to maximize life-changing benefits, including

Improved sexual performance

Improves skin tone and elasticity

increases energy and stamina

These benefits are seen when low hormone levels are treated in hypogonadal and andropausal men. Follow-up is the key to success for our patients and Royal Medical Center

90 days after beginning the powerful hormone replacement therapy program, the patient will be required to follow up with additional labs. This is to determine that the diagnosis and dosages are on target. If we are not pleased with your levels, the regimen will be altered to suit the best results for the patient.

Physicals will be conducted at least once a year or per request by the physician.

*Patients using testosterone supplements should seek medical attention immediately is symptoms of a heart attack or stroke are present, such as:

The rest is here:
Testosterone Replacement Therapy - Royal Medical Center

Biogen (BIIB) and Auxilium Pharmaceuticals (AUXL) Head to Head Comparison – TheOlympiaReport

Posted on by

Biogen (NASDAQ: BIIB) and Auxilium Pharmaceuticals (NASDAQ:AUXL) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitabiliy, analyst recommendations, earnings and institutional ownership.

Institutional & Insider Ownership

88.8% of Biogen shares are held by institutional investors. 0.3% of Biogen shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Biogen and Auxilium Pharmaceuticals net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Biogen and Auxilium Pharmaceuticals, as reported by MarketBeat.com.

Biogen currently has a consensus price target of $331.23, indicating a potential upside of 15.23%. Given Biogens higher possible upside, equities research analysts plainly believe Biogen is more favorable than Auxilium Pharmaceuticals.

Valuation & Earnings

This table compares Biogen and Auxilium Pharmaceuticals gross revenue, earnings per share (EPS) and valuation.

Biogen has higher revenue and earnings than Auxilium Pharmaceuticals.

Summary

Biogen beats Auxilium Pharmaceuticals on 9 of the 9 factors compared between the two stocks.

Biogen Company Profile

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkins lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Companys product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Auxilium Pharmaceuticals Company Profile

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company that focuses on developing and marketing products to predominantly specialist audiences. Its core therapeutic focus continues to be in the area of urology, with an anchor position in mens healthcare. The companys products include Testim (testosterone gel) and testosterone gel are indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; TESTOPEL offers men an option that provides a long-acting androgenic effect; Striant (testosterone buccal system) CIII is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; STENDRA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction; among others.

Receive News & Ratings for Biogen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biogen Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.

Read the rest here:
Biogen (BIIB) and Auxilium Pharmaceuticals (AUXL) Head to Head Comparison - TheOlympiaReport

Testosterone Replacement Therapy (TRT) – Protocol and 1 Week Update – Video

Posted on by


Testosterone Replacement Therapy (TRT) - Protocol and 1 Week Update
Gym is closed due to snow!!! So instead, let #39;s talk about my treatment protocol. Have I noticed any effects? And finally, some posing of my physique (I #39;m proud of what I accomplished as a...

By: TRT Brah

See original here:
Testosterone Replacement Therapy (TRT) - Protocol and 1 Week Update - Video

INTERESTING RESULTS… | Blood Work Update (Testosterone Replacement Therapy) – Video

Posted on by


INTERESTING RESULTS... | Blood Work Update (Testosterone Replacement Therapy)
I had my blood drawn on Feb 27 and was told results would not be in for 3 weeks! LIES lol. Results have come back today 02/10/2015 and the results were NOT WHAT I WAS EXPECTING. This video...

By: bignoknow

Continued here:
INTERESTING RESULTS... | Blood Work Update (Testosterone Replacement Therapy) - Video

Testosterone Replacement Therapy Market Outlook and Forecasts 2019-2024 – Capacities, Production, Consumption, Trade Statistics, and Prices – Hitz…

Posted on by

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Testosterone Replacement Therapy Market. The Testosterone Replacement Therapy Market has been analyzed By Product Type (Gels, Injections, Patches, Other) and By Application (Hospitals, Clinics). The Testosterone Replacement Therapy Market has been analyzed By Region (North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)) for the historical period of 2014-2018 and the forecast period of 2019-2024.

The report is compiled with the use of advanced tools and the latest primary and secondary research methodologies. Our experienced panel of analysts gathers information and data from annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

Available Exclusive Sample Copy of this Report @ https://www.amplemarketreports.com/sample-request/global-testosterone-replacement-therapy-market-280641.html

The report also presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market.

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

On the basis of product, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into Gels, Injections, Patches, Other

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including Hospitals, Clinics

Inquire more or share questions if any on Purchase of this report or Customized Report, Contact Our Expert at https://www.amplemarketreports.com/enquiry-before-buy/global-testosterone-replacement-therapy-market-280641.html

About Ample Market Research

Ample Market Research provides comprehensive market research services and solutions across various industry verticals and helps businesses perform exceptionally well. Attention to detail, consistency, and quality are elements we focus on. However, our mainstay remains to be knowledge, expertise, and resources to make us industry players.

Our mission is to capture every aspect of the market and offer businesses a document that makes solid grounds for crucial decision making.

Contact Address:

William James

Media & Marketing Manager

Call: +1 (530) 868 6979

Email: sales@amplemarketreports.com

Address: 3680 Wilshire Blvd, Ste P04 1387 Los Angeles, CA 90010

https://www.amplemarketreports.com

Read more from the original source:
Testosterone Replacement Therapy Market Outlook and Forecasts 2019-2024 - Capacities, Production, Consumption, Trade Statistics, and Prices - Hitz...

Q&A #2 | Feeling Normal Possible After Depression? Weight Loss on TRT, Guys Who Hit On Me + MORE – Video

Posted on by


Q A #2 | Feeling Normal Possible After Depression? Weight Loss on TRT, Guys Who Hit On Me + MORE
Another awesome Q A covering topics of Mental Health, Testosterone Replacement Therapy, Personal, Random questions. Q A #2 Questions and time links: 0:03 I...

By: bignoknow

Read the rest here:
Q&A #2 | Feeling Normal Possible After Depression? Weight Loss on TRT, Guys Who Hit On Me + MORE - Video

Testosterone Replacement Therapy | Titan Men’s Health

Posted on by

League City & Friendswood Testosterone Therapy

Welcome to Titan T-Center & Weight Loss, League City and Friendswood, Texas finest testosterone replacement therapy clinic. Our clinic is outfitted with the latest technologies to provide our patients with efficient,safe and accurate results. In addition to our modern equipment, the medical professionals at our facilityare some of the most skilled and knowledgeable individuals in the industry. To all of us here, providing premier testosterone therapy requires more than just basic medical treatment. Our staff believes in building relationships and improving the lives of each and every individual that walks through our door.

Low testosterone, or hypogonadism, is a condition in which the bodys natural production of the hormone is below normal levels. By the age of 30, it is very common for men to begin seeing a decline in testosterone. Men may see a variety of symptoms, including but not limited to, a decrease in sex drive. Although age plays a factor in the production of testosterone, diabetes and excessive weight, have been associated with the condition as well.

Although testosterone supplements may be available in several forms, testosterone injections are believed to be safer and more effective than a pill. Oral testosterone is available, however, it is believed that testosterone taken orally may damage the liver. Furthermore, testosterone injections go directlyinto thebloodstream, making each treatment more effective.

Titan T-Center & Weight Loss is here to help you determine whether or not youmay be in need of therapy to lift your testosterone levels. We encourage you to look through the rest of our website to learn more about low t and its impact on your day-to-day life. Should you have any questions or if you would like to come in for a visit, contact us your convenience. Titan T-Center serves patients residing all over the League City and Friendswood areas.

Read the original post:
Testosterone Replacement Therapy | Titan Men's Health

Male Testosterone Therapy – Renew Man

Posted on by

Many of the problems associated with andropause (or male menopause), and low testosterone (also known as low T),can be overcome withhormone replacement therapy for men. The primary goal for any quality hormone replacement program should be to restore testosterone to healthy levels. However, testosterone doesnt function within a vacuum. There are other critical hormones in the picture that must be monitored, tooespecially estrogen and thyroid.

At Renew Man we offer two safe and effective methods to administer testosterone.

About 95% of our clients use testosterone injections to increase their testosterone levels. Those usingtopical creamtend to do so because they are needle-phobic. At Renew Man we recommend the use oftestosterone injectionsfor our clients who dont have an issue with needles. Heres why:

Testosterone creamhas its benefits, especially for men who prefer not to use needles for theirtestosterone treatment.

Testosterone pellets were first introduced in 2005 as a method for replacing testosterone. Atestosterone pelletis a small, half-inch long pellet that is surgically placed under the skin and releases testosterone into your system for about 4 to 6 months. The use of pellets grew in popularity for about a year, until those using them recognized their limitations:

Testosterone patches have been around for quite some time, and were very popular until about 4 years ago. Patches involve the use of a commercially produced patch that is usually applied to the scrotum:

At Renew Man, we do not use testosterone pellets or patches, nor do we use any unsafe or unproven delivery methods fortestosterone therapy. If it isnt safe, and if it isnt effective, it will not be a part of any treatment program we provide.

Testosterone replacement therapy is safe and effectiveif you work with a trained physician, and a quality program. Renew Man has been at the cutting edge of hormone replacement for men since 1999. Give us a call, and let us impress you with what we know. You can reach us at 800-859-7511, or request a consultation through ourcontact form.

Read more:
Male Testosterone Therapy - Renew Man

Go or no go? Agile and Lipocine hope to make it third time lucky – Vantage

Posted on by

After some huge US approvals in recent months, November is shaping up to be quieter. There are no decisions on future blockbusters set for next month, Vantages regular PDUFA analysis shows.

However, some of the upcoming verdicts will still be a big deal for the companies involved. This includes Agile Therapeutics and Lipocine, which hope to bounce back from complete response letters for the Twirla contraceptive patch and the testosterone replacement therapy Tlando respectively.

Twirla's chances of getting approved got a boost yesterday, with an FDA advisory committee voting 14-1 that the benefits of the projects outweigh its risks an unexpected outcome given scathing briefing documentsreleased on Monday. The agency questioned the patch's efficacy, thoughAgile put unimpressive results from the pivotal Secure trial down to a high number of obese participants, in whom contraceptives do not work as well.

The FDA questioned Twirla's efficacy even in non-obese women, however, and also raised doubts about whether the project is a low-dose, and therefore potentially safercontraceptive, as Agile has claimed. Shares in the company recovered today after slumping on the briefing docs, but investors' wild ride might not be over yet.

Meanwhile, Lipocine will hope that an ambulatory blood pressure study will answer questions raised in the FDAs May 2018 CRL. The company believes that Tlando, an oral therapy, will have an edge over injectable testosterone products. Another oral contender got the FDA nod earlier this year, Clarus Therapeutics Jatenzo, andLipocine is embroiled in a legal wrangle with Clarus over intellectual property.

A project that should get a smoother ride is Shionogis S-649266, or cefiderocol, a novel antibiotic targeting Gram-negative pathogens. The project recently got an adcom thumbs up, with panellists voting14-2 in favour ofapproval for patients with complicated urinary tract infections and limited or no alternative treatment options.

The project has also shown promise in pneumonia. Still, as with many antibiotics, especially those saved for drug-resistant infections, succeeding commercially will be trickier.

Meanwhile, Redhill Biopharmas Talicia, which combines two antibiotics and a proton pump inhibitor, is awaiting a verdict in Helicobacter pylori infection. It has a good shot after a positive result in the Eradicate Hp2 trial, and a recent tie-up with Cosmo Pharmaceuticals should also give Redhill sufficient funds for launch.

However, sales expectations are not huge, with EvaluatePharma consensus predicting $27m in 2024.

Supplements

As for potential supplementary approvals, Lilly and Boehringer hope to get cardiovascular data on the label of their DPPIV inhibitor Tradjenta. However, the product has only shown noninferiority to placebo in the Carmelina study; with other diabetes drugs like the SGLT2s and GLP1s showing cardioprotective effects, the DPPIV class has been put in the shade.

Other decisions, including a verdict on Pfizers Humira biosimilar, continue to be expected sometime in the fourth quarter.

The biggest regulatory event of November is not an approval but rather an advisory committee meeting, for Amarins Vascepa. On November 14 panellists will consider the products expanded use for the reduction of cardiovascular events in patients with high triglycerides; the FDA had previously been expected to make a call here in September.

EvaluatePharma consensus forecasts 2024 Vascepa sales of $2.2bn, but Leerink analysts believe that, if the drug does get expanded approval, US revenues could exceed $4bn.

Original post:
Go or no go? Agile and Lipocine hope to make it third time lucky - Vantage


  1. Testosterone Physicians